Ankaa Ventures

We’re a venture capital fund focused on investing in the best Australian and New Zealand technology founders. AirTree's mission is to back founders from the very start with strong conviction. We’re long term partners and we give founders an unfair advantage to turn their audacious visions into reality. We’ve had the privilege of partnering with over 80 of the fastest growing and most impactful tech companies that are transforming a wide variety of industries. In 2022, we launched a new fund with $200 million dedicated to seed stage companies and $50 million to Web3 projects. We're excited to back the next generation of future builders. If that’s you, get in touch. $1.3B Funds Under Management 81 Companies Funded 1000+ Portfolio Jobs Our philosophy It’s never too early to reach out We back the audacious and unrelenting right from the start. Great ideas know no borders We back founders with global ambitions across all industries and sectors. You’re in the driver’s seat It’s your vision, your dream. You know what’s best for your customers and team. We’ll be hands-on when you need, clear air when you don’t. In it for the long haul, through thick and thin It’s easy to be there when you’re on a winning streak. We’ll be your unfair advantage when the chips are down too. Opening up the black box that’s VC Fundraising is a stressful distraction. We’re open, transparent and responsive, so you can focus on building.

We are a highly specialized venture capital firm dedicated to unlocking value in the critical, often undervalued, sector of pre-regulatory approved diagnostic platforms. We exclusively target opportunities where the core technical development risk has been substantially mitigated, but where the perceived regulatory hurdle remains high. We see this intersection as the optimal point for strategic investment, enabling us to partner with companies that possess high-growth potential and a clear path to market. Our investment thesis is powered by a unique blend of deep clinical rigor and disciplined business acumen. We do not just provide capital; we take an active operational role within our portfolio companies, leveraging our expertise—developed through decades of experience in clinical practice, advanced scientific research, and financial management—to serve as an extension of the management team. This hands-on approach allows us to directly de-risk complex regulatory pathways, accelerate product validation, and transition novel science into commercially successful, life-changing platforms.

We invest in boldly ambitious businesses, partnering with founders with vision, courage and the capacity to execute. We're experienced investors, we've invested in 35+ companies to date and in 2019 we launched our €80m third fund. We search for early-stage companies solving complex problems with breakthrough solutions. We have a European focus and invest in B2B opportunities in: cybersecurity, data and applications, infrastructure, devops, components and digital health.

We help visionary founders build the future. We are specialists Our expertise is what sets us apart. We apply our industry experience and knowledge of emerging technology to develop specific themes that guide our investments. We recognize greatness Our process is selective and primarily outbound. We look for founders at the forefront of fintech, deep tech, and enterprise technologies and move with speed and conviction when we find them. We are every-stage Our capital is flexible. We can enter and lead deals at any stage and can stay with a company through the entirety of their growth journey, from seed-stage to IPO. Our investments are grounded in thematic research and the expertise of our people Investing in the spaces we know best allows us the opportunity to be better partners to our portfolio companies. Fintech We back founders who are disrupting legacy fintech infrastructure, democratizing access to financial products, and providing new tools to financial services consumers. Deep Tech We focus on the real-world application of groundbreaking technologies, including robotics, next-generation manufacturing, and self-learning algorithms. Enterprise We invest in the decentralized future of business through companies specializing in cybersecurity and enterprise applications. We are expert capital Point72 Ventures is a global venture capital fund that builds on Steven A. Cohen’s decades of public and private market investing experience. We are primarily based in New York and Menlo Park, with team members across the U.S. and Europe. We are a diverse group of domain specialists who really like what we do.

Morpheus Ventures is a venture capital fund that invests in early stage companies and helps them avoid traditional roadblocks on their path to hyper-growth. Our CEOs regularly seek our guidance because our team is made up of specialists across various disciplines that can serve as professional problem solvers when complex situations arise. Do you have that one friend you can call Friday at midnight when you need real help? That’s us; we’re experts at navigating times of challenge, from inception through all phases of growth. Consider the biggest roadblocks that can derail a company as they scale. The way we see the world, gone are the days when startups simply have a clear and linear path from Series A to unicorn. Nowadays, something or someone will try to block their path – a competitor, regulator, customer, rogue employee, or attorney general. That’s where we come in. We’re a team of former CEOs, operators, specialists, engineers, and legal experts trained at startup complexity, and we’re here to help.

An investment fund dedicated to partnering with entrepreneurs transforming the future of health through innovation and technology.